Expect 10-15% upside in Ranbaxy: Srivastava

39818 Investors following Ranbaxy Labs. Share this News with them.

0

Like this story, share it with millions of investors on M3

Expect 10-15% upside in Ranbaxy: Srivastava

Ajay Srivastava, Dimensions Consulting feels that one can expect 10-15% upside in Ranbaxy. There is some good news, which should come and get factored in terms of their better operating performance and their domestic performance. The segregation of the two companies, i.e. the research company, the NC company and this one should be strong positive.

Post your opinion here

 

0

Tweet

Share on Tumblr

Excerpts from Bazaar on CNBC-TV18 Watch the full show » RELATED NEWS Sell Ranbaxy Laboratories: Mohoni Ranbaxy honours Indian Scientists & Young Science Scholars ALSO READ See previous views by Ajay Srivastava See what other Experts & Brokerages are saying about Ranbaxy Labs See messages about Ranbaxy Labs Ranbaxy Labs BSE | NSE 28/05/12 Are Mutual Funds betting on Ranbaxy Labs?

Ajay Srivastava , Dimensions Consulting is of the view that one can expect 10-15% upside in Ranbaxy Laboratories .

Srivastava told CNBC-TV18, "In Ranbaxy I think Rs 380 is certainly among the lows that the stock has. There is some good news, which should come and get factored in terms of their better operating performance and their domestic performance and the segregation of the two companies, i.e. the research company, the NC company and this one should be strong positive. Not too much have an upside, but I think 10-15% upside is definitely on the cards."